Başaran, G., Twelves, C., , Cortés, J., & Awada, A. (2017). Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer. Cancer Treatment Reviews, 63, 144-155. https://doi.org/10.1016/j.ctrv.2017.12.002 (Original work published 2017)

Turner, N., Finn, R., Martin, M., Im, S., DeMichele, A., Ettl, J., … Gelmon, K. (2018). Clinical Considerations of the Role of Palbociclib in the Management of Advanced Breast Cancer Patients With and Without Visceral Metastases. Annals of Oncology : Official Journal of the European Society for Medical Oncology. https://doi.org/10.1093/annonc/mdx797 (Original work published 2018)

Schneeweiss, A., Park-Simon, T., Albanell, J., Lassen, U., Cortés, J., , … Cervantes, A. (2018). Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer. Investigational New Drugs. https://doi.org/10.1007/s10637-018-0562-4 (Original work published 2018)